4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-393124
Director sold 10,000 shares at an average $110.69 ($1,106,940)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WILSON JAMES N · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-15 | Sale : show line 1 in the form 10b5-1 | −6,800 | $110.27 | $749,835 | 1,067,743 | I |
| 2026-09-15 | Sale : show line 2 in the form 10b5-1 | −400 | $110.84 | $44,335 | 1,067,343 | I |
| 2026-09-15 | Sale : show line 3 in the form 10b5-1 | −2,800 | $111.70 | $312,771 | 1,064,543 | I |
| Open-market sales · 10,000 sh · avg $110.69 · $1,106,940 | ||||||
Loading xslF345X06/ownership.xml…